arginine vasopressin has been researched along with mibefradil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Laher, I; Lam, E; Skarsgard, P | 1 |
Barakat, J; Brueggemann, LI; Byron, KL; Cribbs, LL; Martin, BL | 1 |
3 other study(ies) available for arginine vasopressin and mibefradil
Article | Year |
---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Inhibition of myogenic tone by mibefradil in rat cerebral arteries.
Topics: Animals; Arginine Vasopressin; Benzimidazoles; Cerebral Arteries; Dose-Response Relationship, Drug; Male; Mibefradil; Muscle, Smooth, Vascular; Myogenic Regulatory Factors; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking.
Topics: Adenoviridae; Amino Acid Sequence; Animals; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cells, Cultured; Membrane Transport Proteins; Mibefradil; Molecular Sequence Data; Muscle, Smooth, Vascular; Rats; Vasoconstrictor Agents | 2005 |